Do you know people having bladder cancer will increase the survival rate with padcev?
People often think India is not well equipped with the treatment of cancer which is just a myth now. The reputed cancer hospitals of India are specialised in treating the cancer patient effectively and efficiently. Our oncologists are spreading the news about padcev. In this article we are going to discuss about does padcev really improves the survival rate of the patient.
Padcev which is known as enfortumab vedotin increases the survival rate of the patient as compared to chemotherapy with patients having urothelial cancer well treated with chemotherapy based on platinum and immunotherapy. With the advancement of the health sector now cancer treatment in India is possible. In this article, we are going to discuss how padcev increases the survival rate of the patient suffering from cancer.
What is urothelial cancer?
This is a common type of bladder cancer where it starts in cells known as urothelial which lines the other parts such as the urethra, bladder, ureters, kidney and other parts. The urothelial cells are also known as transitional cells which can stretch as well as can change the shape without even breaking. The cancer specialist starts the treatment with chemotherapy based on platinum but it might contain poor results if a patient were unable to use cisplatin.
What is Padcev?
It is a called enfortumab vedotin which is used to treat adult patients. It is an antibody-drug which targets nectin-4 which is a protein found in urothelial cancer cells. The antibody is having a chemotherapy drug that damages cellular structures which are known as microtubules and it also stops division of cells. Our oncologist has found out that the survival rate of the cancer patient has increased by 50 percent in 12 months and 34 percent in 18 months.
Padcev Vs Chemotherapy
To check the result of padcev vs chemotherapy our oncologist has tried on about 600 patients treated with metastatic urothelial cancer which are before treated with chemotherapy based on platinum. The objectives of the treatments that are mentioned below:
Survival of the patient
Duration of patient response
How many patients can tolerate
The quality of life
What is chemotherapy?
Chemotherapy is a type of therapy in which oncologists will use the drug to damage cancer from the patient. Chemotherapy stops the cancer cells from growing and spreading in the human body.
To padcev patients
The oncologist was giving padcev to the patients on 1, 8, and 15 over for 28 days.
To chemotherapy patients
The oncologist was giving docetaxel, vinflunine, paclitaxel on 1 day over for 21 days.
Results of the treatment
Our oncologist has found that padcev is beneficial for cancer patients which also decreases the risk of death of the patient as well as provides free survival to the patient. It also discovered that the treatment saves and patients can tolerate it.
Final Thoughts
We hope you understand that people having bladder cancer will increase the survival rate with padcev. If you are facing bladder cancer then need not to worry. Our Country India will be able to provide you with such treatment which will not only help you in staying for a longer period and it is also tolerable.
